European Court of Justice: Pfizer LIABLE for damage if its COVID-19 injection is defective
07/24/2024 / By Ava Grace
According to a ruling by the European Court of Justice (ECJ), drug manufacturer Pfizer is liable for damage if its Wuhan coronavirus (COVID-19) injection is found to be defective.
The ECJ’s July 17 ruling argued that the idea of COVID-19 vaccine makers having limited liability for vaccine-related injuries or deaths is not entirely true. “A producer is liable for the damage caused by a defect in its product and its liability cannot be limited or excluded,” the decision stated. “However, there is no provision … that prohibits a third party from reimbursing the damages which a producer has paid as a result of its product being defective.”
The Daily Expose continued: “That means if Pfizer’s product is defective and people are harmed by that product, then the victims can seek damages from Pfizer. For any damages that Pfizer pays out, Pfizer can seek reimbursements from a third party – for example, BioNTech.”
According to the ECJ ruling, “a producer is liable for the damage caused by a defect in its product.” (Related: Former CDC Director calls out FDA’s under-reporting of COVID-19 vaccine side effects in congressional hearing.)
“Producer” is defined as “the manufacturer of a finished product, the producer of any raw material or the manufacturer of a component part and any person who, by putting his name, trade mark or other distinguishing feature on the product presents himself as its producer.” It also applies to any person who imports a product for sale or any form of distribution in the European Community in the course of their business.
Meanwhile, the definition of “damage” includes “damage caused by death or by personal injuries.” According to the Expose, “the COVID-19 vaccines have caused death and personal injury” despite the public being deceived about the injections being “safe and effective.”
ECJ also deems efforts to conceal vaccine contracts ILLEGAL
The ECJ’s July 17 ruling also annulled the European Commission’s (EC) decision to conceal certain parts of COVID-19 vaccine contracts inked by EC President Ursula Von der Leyen. The concealment was done as part of her efforts to gain support for her reelection bid.
Back in October 2021, Members of the European Parliament (MEPs) from the Green bloc asked for access to the COVID-19 vaccine contracts with Pfizer negotiated by the EC to know the terms and conditions of the agreements. However, they were only provided with redacted versions of the said contracts.
But the ECJ ruled that Von der Leyen was wrong to conceal details of its multi-billion euro deals for the COVID-19 vaccines. It also noted that the EC did not give sufficient access to the purchase agreements.
This ruling serves as a major blow to Von der Leyen, who is seeking a second term as EC president. She was already under scrutiny for allegedly keeping secret and deleting text messages with Pfizer CEO Albert Bourla over vaccine purchases in a controversy dubbed “Deletegate.”
“The new European Commission must now adapt their handling of access to documents requests to be in line with today’s ruling,” said Tilly Metz of Luxembourg, one of the Green MEPs who filed the lawsuit.
Head over to BigPharmaNews.com for similar stories.
Watch this video about EC President Ursula Von der Leyen being accused of secretly negotiating with Pfizer CEO Albert Bourla for COVID-19 vaccines.
This video is from the Conspiraciones y Noticias channel on Brighteon.com.
More related stories:
Pfizergate: Ursula von der Leyen’s shady COVID vaccine deals prove she can get away with anything.
OBEY OR SUFFER: EU Chief Ursula von der Leyen calls for creation of GLOBAL DIGITAL ID SYSTEM.
Sources include:
Submit a correction >>
Tagged Under:
Albert Bourla, Big Pharma, conspiracy, court ruling, covid-19, damages, defective product, European Court of Justice, liable, pandemic, Pfizer, pharmaceutical fraud, Ursula von der Leyen, vaccine, Wuhan coronavirus
This article may contain statements that reflect the opinion of the author
RECENT NEWS & ARTICLES
